Flowable Scaffold for MIS Repair of Bone Damage

A new ultraporous scaffold can be administered in minimally invasive surgical (MIS) procedures to help repair bone defects in the spine, extremities, and pelvis.

When mixed with bone marrow, this biomaterial becomes a flowable material that can be administered directly into a bone defect to promote healing and bone regrowth. Called Scaffold Foam Flow, the product is part of the Vitoss line of Orthovita, Inc. (Malvern, PA, USA). The company has also announced the availability of a disposable delivery system called Impack, which offers surgeons a convenient way to administer Scaffold Foam Flow into deep voids during surgical procedures. Because it is easier to mix and handle, Scaffold Foam Flow together with the delivery system make it possible for surgeons to use Vitoss for a broad range of surgical needs not otherwise covered by Vitoss.

The Vitoss Scaffold technology is based on a highly porous structure that is capable of absorbing 300% of its own weight in bone marrow, a proven source of bone-healing cells and signaling factors. The structure offers significant advantages in promoting and guiding the three-dimensional regeneration of new bone. Foam Flow becomes putty-like when mixed with a liquid material, allowing surgeons to shape it or extrude it for use in the treatment of a broad range of bone defects.

"With Vitoss Scaffold Foam Flow, surgeons now have an option that matches the high porosity and healing capabilities of natural bone while also offering the highest levels of convenience and flexibility for many surgical needs,” said Antony Koblish, president and CEO of Orthovita.




Related Links:
Orthovita